Drug-Resistant Epilepsy (DRE) Goals for Epilepsy Clinical Visits MHealth Epilepsy Visit Planner Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this project is to conduct a trial to assess whether patients that receive a tablet-based waiting room priority communication tool (the Epilepsy Visit Planner) have improved outcomes compared to patients that do not receive the tool. The project's hypotheses are: * Patients that receive the Epilepsy Visit Planner will have improved patient-provider communication compared to the non-planner group. * Patients that receive the Epilepsy Visit Planner will have improved quality of life scores. * The Epilepsy Visit Planner will score highly on process measures of feasibility and acceptability, demonstrating suitability for future larger scale study. Additionally, there is a related survey project that is not part of the clinical trial and will not be included in this registration information.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Adults with drug-resistant epilepsy

⁃ Participants receiving care through the Epilepsy clinics at the University of Michigan

• University of Michigan epilepsy providers

Locations
United States
Michigan
University of Michigan
RECRUITING
Ann Arbor
Contact Information
Primary
Queen Bolden
qmbolden@umich.edu
734-615-5495
Time Frame
Start Date: 2023-09-27
Estimated Completion Date: 2027-01-01
Participants
Target number of participants: 162
Treatments
Other: Standard care arm - patient participants
This group will be enrolled first.
Experimental: Intervention arm (Epilepsy Visit Planner) - patient participants
This group will be enrolled after the standard care arm enrollment is completed.
Other: Intervention arm (Epilepsy Visit Planner) - provider participants
Epilepsy providers will be recruited from the University of Michigan (approximately 10 providers).
Related Therapeutic Areas
Sponsors
Leads: University of Michigan
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)

This content was sourced from clinicaltrials.gov